Log in
menu
RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact
All Categories
--------------
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
search
arrow_back_ios
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
arrow_forward_ios
Access to Medicine Index
+
Access to Medicine Overall Score
+
Answer
history
edit
build
2014
GlaxoSmithKline
United Kingdom
3.3
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Novo Nordisk
Denmark
3
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Merck KGaA
2.8
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Novartis
Switzerland
2.8
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Johnson&Johnson
New Jersey (United States)
2.8
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Gilead Sciences
California (United States)
2.8
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Sanofi
France
2.6
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
AbbVie Inc.
Illinois (United States)
2.6
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Merck & Co
New Jersey (United States)
2.6
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Bayer AG
Germany
2.5
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Eisai
Japan
2.5
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Roche Holding
Switzerland
2.3
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Pfizer
New York (United States)
1.9
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
AstraZeneca
United Kingdom
1.9
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Eli Lilly & Co
Indiana (United States)
1.7
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Astellas Pharma (UK)
United Kingdom
1.6
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Daiichi Sankyo
Japan
1.5
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2014
Takeda Pharmaceutical
Japan
1.5
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2016
Oriflame Cosmetics AB
Sweden
Unknown
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2018
Oriflame Cosmetics AB
Sweden
comment
Unknown
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
«
1
2
»
1 - 20 of 28